Serina Therapeutics (SER) Net Shares Issued and Repurchased (2017 - 2024)

Serina Therapeutics has disclosed Net Shares Issued and Repurchased across 8 years of filings, most recently posting $641000.0 for Q2 2024.

• In Q2 2024, Net Shares Issued and Repurchased changed N/A year-over-year to $641000.0; the TTM figure through Jun 2024 stood at $641000.0 (changed N/A YoY), while the FY2023 annual figure was $11000.0, up 83.33% from the prior year.
• Net Shares Issued and Repurchased came in at $641000.0 for Q2 2024 at Serina Therapeutics, up from $72000.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $641000.0 in Q2 2024 to a low of $6000.0 in Q4 2022.
• Average Net Shares Issued and Repurchased over 5 years is $230714.3, with a median of $72000.0 recorded in 2024.
• Year-over-year, Net Shares Issued and Repurchased jumped 87.46% in 2021 and slumped 98.94% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $303000.0 in 2020, then jumped by 87.46% to $568000.0 in 2021, then slumped by 98.94% to $6000.0 in 2022, then soared by 83.33% to $11000.0 in 2023, then surged by 5727.27% to $641000.0 in 2024.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $641000.0 in Q2 2024, $72000.0 in Q1 2024, and $11000.0 in Q4 2023.